Mayne Pharma reported AUD5.67M in Loan Capital for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Ansell ANN:AU USD 467.6M 74.2M
Cochlear COH:AU AUD 175.2M 53.9M
CSL CSL:AU USD 5.16B 33.1M
Ecofibre Ltd EOF:AU AUD 17.23M 8.87M
Healius Ltd HLS:AU AUD 1.56B 287.3M
Integral Diagnostics Ltd IDX:AU AUD 323.78M 6.8M
Medical Developments International Ltd MVP:AU AUD 2.59M 121K
Nanosonics Ltd NAN:AU AUD 9.16M 5.52M
Next Science Ltd NXS:AU USD 1.1M 943.92K
Polynovo Ltd PNV:AU AUD 9.21M 1.88M
Probiotec Ltd PBP:AU AUD 84.34M 4.48M
Ramsay Health Care RHC:AU AUD 10.3B 1.88B
ResMed RMD:AU USD 1.79B 1.03B
Sigma Healthcare Ltd SIG:AU AUD 231.5M 66.24M
Sonic Healthcare SHL:AU AUD 2.67B 209.78M
Telix Pharmaceuticals Ltd TLX:AU AUD 2.01M 104K